Patents by Inventor Luz-Maria Guzman

Luz-Maria Guzman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020115591
    Abstract: Disclosed is a gene, termed “S-yneS,” found in Streptococcus pneumoniae, which is essential for survival for a wide range of bacteria. This gene and the S-yneS polypeptide that it encodes, as well as homologs and orthologs thereof (collectively referred to as “yneS” genes and polypeptides) can be used to identify antibacterial agents for treating a broad spectrum of bacterial infections.
    Type: Application
    Filed: February 5, 2002
    Publication date: August 22, 2002
    Applicant: Millennium Pharmaceuticals, Inc., a Delaware corporation
    Inventors: Christian Fritz, Philip Youngman, Luz-Maria Guzman
  • Patent number: 6437108
    Abstract: Disclosed are 23 genes, termed “GEP” genes, found in Streptococcus pneumonia, which are located within operons that are essential for survival. Also disclosed is a related essential gene found in Bacillus subtilis. These genes and the polypeptides that they encode, as well as homologs thereof, can be used to identify antibacterial agents for treating bacterial infections such as streptococcal pneumonia.
    Type: Grant
    Filed: December 30, 1998
    Date of Patent: August 20, 2002
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Philip Youngman, Christian Fritz, Christopher Murphy, Luz-Maria Guzman
  • Patent number: 6372448
    Abstract: Disclosed are genes found in Streptococcus pneumoniae that are essential for survival for a wide range of bacteria. These genes are termed “S-ylqF,” “S-yqeG,” “S-yybQ,” “S-yerL,” and “S-ysxC.” These genes and the polypeptides that they encode, as well as homologs and orthologs thereof can be used to identify antibacterial agents for treating a broad spectrum of bacterial infections.
    Type: Grant
    Filed: December 30, 1998
    Date of Patent: April 16, 2002
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Christian Fritz, Philip Youngman, Luz-Maria Guzman